Bevespi Aerosphere is a medicine used in adults to relieve the symptoms of chronic obstructive pulmonary disease (COPD). COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing. Bevespi Aerosphere is used for maintenance (regular) treatment. It contains the active substances glycopyrronium bromide and formoterol.
Therapeutic Indication
### Therapeutic indication Bevespi Aerosphere is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Therapeutic Area (MeSH)
ATC Code
R03AL07
ATC Item
formoterol and glycopyrronium bromide
Pharmacotherapeutic Group
formoterol and glycopyrronium bromide
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| glycopyrronium | N/A | 格隆溴铵 |
| formoterol fumarate dihydrate | N/A | Aluminum sulfate |
EMA Name
Bevespi Aerosphere
Medicine Name
Bevespi Aerosphere
Aliases
N/ANo risk management plan link.
